Topical nasal steroid treatment does not improve CPAP compliance in unselected patients with OSAS

Respiratory Medicine

Volumn 105, Issue 2, 2011, Pages 310-315

  Strobel, Werner ^a   Schlageter, Manuel ^a   Andersson, Morgan ^b   Miedinger, David ^a   Chhajed, Prashant N ^a   Tamm, Michael ^a   Leuppi, Jörg D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Apnea; Sleep; Steroid

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO;

ADULT; ARTICLE; DEVICE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FLOWMETER; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; TREATMENT DURATION;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, TOPICAL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 78651404260     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.10.003     Document Type: Article

References (16)

1. M. Kryger Principles and practice of sleep medicine 1989 WB Saunders Philadelphia
2. T. Young, L. Finn, and H. Kim Nasal obstruction as a risk factor for sleep-disordered breathing J Allergy Clin Immunol 99 2 1997 S757 S762 The University of Wisconsin Sleep and Respiratory Research Group
3. C.R. Canova, S.H. Downs, A. Knoblauch, M. Andersson, M. Tamm, and J.D. Leuppi Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea Respiration 71 2 2004 138 143
4. W.T. McNicholas, S. Tarlo, P. Cole, N. Zamel, R. Rutherford, and D. Griffin Obstructive apneas during sleep in patients with seasonal allergic rhinitis Am Rev Respir Dis 126 4 1982 625 628
5. T.J. Craig, S. Teets, E.B. Lehman, V.M. Chinchilli, and C. Zwillich Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids J Allergy Clin Immunol 101 5 1998 633 637
6. G. Nilius, K.J. Franke, U. Domanski, and K.H. Ruhle [Upper airway complaints of patients with obstructive sleep apnea - effect of CPAP] Pneumologie (Stuttgart, Germany) 61 1 2007 15 19
7. M. Holmstrom, G.K. Scadding, V.J. Lund, and Y.C. Darby Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow Rhinology 28 3 1990 191 196
8. C. Iber, S. Ancoli-Israel, and A. Chesson The AASM manual for the scoring of sleep and associated events 2007 American Academy of Sleep Medicine
9. J. Bousquet, N. Khaltaev, A.A. Cruz, J. Denburg, W.J. Fokkens, and A. Togias Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 Suppl. 86 2008 8 160
10. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society Eur Respir J 16 1993 5 40
11. C. Ahlstrom Emanuelsson, M. Andersson, C.G. Persson, L. Thorsson, and L. Greiff Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis Respir Med 101 6 2007 1106 1112
12. H.M. Engleman, and M.R. Wild Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS) Sleep Med Rev 7 1 2003 81 99
13. J. Krieger, D. Kurtz, C. Petiau, E. Sforza, and D. Trautmann Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers Sleep 19 Suppl. 9 1996 S136 S143
14. J.L. Kiely, P. Nolan, and W.T. McNicholas Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis Thorax 59 1 2004 50 55
15. I. Smith, T.J. Lasserson, and J. Wright Drug therapy for obstructive sleep apnoea in adults Cochrane Database Syst Rev 2 2006 CD003002
16. F.F. Shadan, A.A. Jalowayski, J. Fahrenholz, L.E. Kline, and A. Dawson Nasal cytology: a marker of clinically silent inflammation in patients with obstructive sleep apnea and a predictor of noncompliance with nasal CPAP therapy J Clin Sleep Med 1 3 2005 266 270